GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (STU:7UM) » Definitions » Pre-Tax Income

Ultimovacs ASA (STU:7UM) Pre-Tax Income : €-15.42 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ultimovacs ASA Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ultimovacs ASA's pretax income for the three months ended in Mar. 2024 was €-1.97 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-15.42 Mil. Ultimovacs ASA's pretax margin was %.


Ultimovacs ASA Pre-Tax Income Historical Data

The historical data trend for Ultimovacs ASA's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultimovacs ASA Pre-Tax Income Chart

Ultimovacs ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -6.10 -11.38 -16.23 -16.03 -16.45

Ultimovacs ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.03 -3.71 -4.88 -4.86 -1.97

Competitive Comparison of Ultimovacs ASA's Pre-Tax Income

For the Biotechnology subindustry, Ultimovacs ASA's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultimovacs ASA's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ultimovacs ASA's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ultimovacs ASA's Pre-Tax Income falls into.



Ultimovacs ASA Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ultimovacs ASA's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-18.752+0+-0.033+1.228+1.108
=-16.45

Ultimovacs ASA's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.484+0+-0.031+0.543+0
=-1.97

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-15.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultimovacs ASA  (STU:7UM) Pre-Tax Income Explanation

Ultimovacs ASA's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-1.972/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ultimovacs ASA Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ultimovacs ASA's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultimovacs ASA (STU:7UM) Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Ultimovacs ASA (STU:7UM) Headlines

No Headlines